In addition to coagulation markers, endothelial dysfunction may underlie the increased risk of thromboembolism in COVID-19 as both vWF activity and vWF antigen are increased in COVID-19 ARDS compared to non-COVID-19 ARDS (90). This evidence concerns the gene VWF and Thromboembolism.